Decreased levels of adiponectin lead to altered fatty acid metabolism and long-term liver inflammation, while high serum leptin levels are found in individuals with MASLD and have been associated with HSC activation and liver fibrosis [49]. Here, LEP is linked to metabolic dysfunction-associated steatotic liver disease.